Foundation Medicine, Novartis Partner on Cancer Diagnostic

The deal is Foundation's first with a drug firm, and if the pilot phase is successful the two companies will evaluate opportunities to commercialize the test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.